| OCR Text |
Show 9 [16] Florence Roufosse. Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma. Frontiers in Medicine, 5:49, Apr 2018. [17] Carine Blanchard, Melissa K Mingler, Maria Vicario, J Pablo Abonia, Yi Ying Wu, Thomas X Lu, Margaret H Collins, Philip E Putnam, Susanne I Wells, and Marc E Rothenberg. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. The Journal of Allergy and Clinical Immunology, 120(6):1292–1300, Dec 2007. [18] C Blanchard, A Mishra, H Saito-Akei, P Monk, I Anderson, and M E Rothenberg. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clinical and Experimental Allergy, 35(8):1096–1103, Aug 2005. [19] Li Zuo, Patricia C Fulkerson, Fred D Finkelman, Melissa Mingler, Christine A Fischetti, Carine Blanchard, and Marc E Rothenberg. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. Journal of Immunology, 185(1):660–669, Jul 2010. [20] Hamish Philpott, Barry Kweh, and Francis Thien. Eosinophilic esophagitis: current understanding and evolving concepts. Asia Pacific Allergy, 7(1):3–9, Jan 2017. [21] Alain M Schoepfer, Nirmala Gonsalves, Christian Bussmann, Sébastien Conus, HansUwe Simon, Alex Straumann, and Ikuo Hirano. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. The American Journal of Gastroenterology, 105(5):1062–1070, May 2010. [22] Jean P Li-Kim-Moy, Vivienne Tobias, Andrew S Day, Steven Leach, and Daniel A Lemberg. Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. Journal of Pediatric Gastroenterology and Nutrition, 52(2):147–153, Feb 2011. [23] Jennifer Armbruster-Lee, Cary P Cavender, Jay A Lieberman, and Amali E Samarasinghe. Understanding fibrosis in eosinophilic esophagitis: Are we there yet? Journal of Leukocyte Biology, 104(1):31–40, Jul 2018. [24] Alfredo J Lucendo, Javier Molina-Infante, Ángel Arias, Ulrike von Arnim, Albert J Bredenoord, Christian Bussmann, Jorge Amil Dias, Mogens Bove, Jesús GonzálezCervera, Helen Larsson, Stephan Miehlke, Alexandra Papadopoulou, Joaquı́n Rodrı́guez-Sánchez, Alberto Ravelli, Jukka Ronkainen, Cecilio Santander, Alain M Schoepfer, Martin A Storr, Ingrid Terreehorst, Alex Straumann, and Stephen E Attwood. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterology Journal, 5(3):335–358, Apr 2017. [25] Joshua B Wechsler, Sally Schwartz, Katie Amsden, and Amir F Kagalwalla. Elimination diets in the management of eosinophilic esophagitis. Journal of Asthma and Allergy, 7:85–94, May 2014. [26] Allison R King and August 2012 University of Kansas Drug Information Center Experiential Rotation Students. Gluten content of the top 200 medications: Follow-up to the influence of gluten on a patient’s medication choices. Hospital Pharmacy, 48(9):736–743, Oct 2013. |